← Leaderboards
Andrei A Purmal
Panacos Pharmaceuticals, Inc.
$1,060,000
Attributed
$1,060,000
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,060,000 · 1
By mechanism
R01$1,060,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Panacos Pharmaceuticals, Inc.
Same institution · by research overlap
- Karl Salzwedel$513,175
- John R Chapman$885,413
Others in their field
Top investigators on “Antiseptic Sterilization”
- Elizabeth Joy Brisbois · University Of Michigan At Ann Arbor$2,385,257
- Corinne Constantine · Columbia University Health Sciences$2,044,346
- John M Colford · University Of California Berkeley$1,780,342
- Stephen J. Wagner · American National Red Cross$1,648,365
- Jennifer Ann Neff · Allvivo Vascular, Inc.$1,615,107
- Joel L Williams · Genomex$1,529,539
Research focus
Antiseptic SterilizationAntiviral AgentsBaboonsBlood ToxicologyBlood TransfusionBlood TreatmentErythrocytesHuman TissueLaboratory RabbitLaboratory RatVirus Infection Mechanism
Grant awards (4)
VIRALLY INACTIVATED HUMAN RED CELLS FOR TRANSFUSION$265,000
R01 · FY2004 · HL
VIRALLY INACTIVATED HUMAN RED CELLS FOR TRANSFUSION$265,000
R01 · FY2003 · HL
VIRALLY INACTIVATED HUMAN RED CELLS FOR TRANSFUSION$265,000
R01 · FY2002 · HL
VIRALLY INACTIVATED HUMAN RED CELLS FOR TRANSFUSION$265,000
R01 · FY2001 · HL